Why Turmeric Isn't Enough: Liposomal Curcumin Guide
Eskag Pharma
Share
Turmeric and curcumin are not the same thing, and most people taking turmeric supplements are not getting the clinical benefit the research demonstrates. Turmeric contains only 2-8% curcuminoids by weight, and curcumin itself is poorly absorbed before it reaches your bloodstream in any meaningful amount. Most supplements either contain too little curcumin or use a standard formulation your body cannot absorb effectively, which is why formulation, not dosage, is the decision that matters.
In this blog, we cover the difference between turmeric and curcumin, why most curcumin is wasted, which formulations work, and what clinical trials actually show.
Key Takeaways:
- Turmeric contains only 2-8% curcuminoids; a 500 mg turmeric capsule delivers just 15–40 mg of curcumin.
- Standard curcumin extract is poorly absorbed; systemic concentrations remain negligible even at high oral doses without an enhanced formulation.
- Formulation determines absorption; piperine, phytosome, liposomal, and BCM-95 each improve curcumin bioavailability through different mechanisms.
Quick Answer: Turmeric contains only 2-8% curcumin by weight, and curcumin requires an enhanced formulation, such as liposomal or piperine delivery, to reach effective blood concentrations.
Curcumin and Turmeric Difference: What You Are Buying
Turmeric and curcumin are not the same thing, and most supplements labelled "turmeric" deliver only a fraction of the active compound used in clinical research.
- Turmeric is a spice derived from the root of Curcuma longa. It contains curcuminoids at only 2-8% of its total weight, alongside volatile oils called turmerones, carotenoids, and polysaccharides [1]. However, none are at concentrations high enough to match supplement-level doses.
- Curcumin makes up approximately 75% of the curcuminoid fraction in turmeric. A 500 mg turmeric root capsule delivers only 15-40 mg of curcuminoids, whereas a 500 mg standardised 95% curcumin extract capsule delivers approximately 475 mg.
- Over 65 clinical trials evaluating turmeric's health effects used curcumin extract rather than whole turmeric root; a standardised concentration is required for reproducible dosing and measurable outcomes [2].
- The concentration process used to produce 95% curcumin extract removes turmerones and other volatile oils from the whole root. These compounds have preliminary evidence for bioavailability-enhancing and anti-neuroinflammatory properties that are absent from isolated curcumin.
- Curcumin extract provides a concentrated, measurable dose for targeted conditions, whereas whole turmeric offers a broader phytochemical profile suited to everyday dietary use rather than therapeutic supplementation.
With an understanding of the difference between curcumin and turmeric, let’s explore the bioavailability issue associated with traditional supplements.
The Bioavailability Problem: Why Most Curcumin Is Wasted
Turmeric and curcumin share the same bioavailability problem: curcumin is poorly absorbed, rapidly metabolised, and quickly eliminated from the body before it can reach therapeutic concentrations in the blood.
- Curcumin has three simultaneous problems: poor water solubility, lipophilicity, rapid intestinal and hepatic metabolism into inactive conjugates, and rapid systemic elimination. These three barriers work together to limit curcumin bioavailability regardless of the dose consumed.
- Systemic concentrations of unconjugated curcumin do not exceed the low-micromolar range in humans even after oral doses up to 12 grams, meaning that a standard capsule at recommended doses achieves functionally negligible blood levels.
- Fat marginally improves curcumin absorption, but dietary fat alone cannot overcome the metabolic barrier that converts curcumin into inactive compounds before it reaches circulation.
- Liposomal delivery encapsulates curcumin within phospholipid bilayer vesicles that mimic the body's own cell membranes, bypassing gastrointestinal barriers, protecting curcumin from premature metabolism, and improving systemic delivery compared to standard curcumin extract.
- The results of most systematic reviews on orally administered curcumin should be interpreted with caution, because curcumin bioavailability is widely recognised as a crucial factor yet is rarely addressed in the evidence supporting supplement marketing claims.
Liposomal Curcumin vs Piperine vs Phytosome: What Works Best?
No single curcumin enhancement method works the same way; each solves the absorption problem differently, and the right choice depends on your health goal and medication list.
Here is a tabular representation to understand the difference between them:
|
Formulation |
How It Works |
Bioavailability Gain |
Best For |
|
Encases curcumin in fat vesicles that protect it until absorbed |
13x higher than standard [5]. |
Users who cannot take piperine due to medication interactions |
|
|
Piperine |
Blocks the enzyme that breaks curcumin down before absorption |
20x vs standard curcumin [3]. |
General use, budget-friendly |
|
Phytosome (Meriva) |
Binds curcumin to phospholipids for easier absorption |
29x vs standard curcumin [4]. |
Joint pain and osteoarthritis |
|
Theracurmin |
Reduces curcumin to tiny particles that dissolve more easily |
27x vs standard curcumin |
Less widely available in India |
|
BCM-95 |
Combines curcumin with turmeric's natural oils |
6.93x vs standard curcumin |
Those wanting whole-turmeric phytochemistry |
Note: Bioavailability gains are relative to standard curcumin; individual results vary by dose and health status.
What Does Curcumin Do? Evidence vs Marketing Claims
Curcumin is one of the most studied botanical compounds in clinical research, but the gap between what the evidence supports and what supplement marketing claims is significant and worth understanding before you buy.
Inflammation
A 2024 meta-analysis of 103 randomised controlled trials found high-credibility evidence that curcumin supplementation reduces CRP, one of the most widely used clinical biomarkers of systemic inflammation [6].
Metabolic Health
A 2025 umbrella review confirmed curcumin can reduce blood pressure, improve insulin resistance, reduce blood glucose, and support endothelial function. Beneficial effects on clinical outcomes were reported in 75% of double-blind randomised controlled trials included in the review [7].
Joint Pain
Curcumin shows consistent benefit for osteoarthritis symptoms across multiple RCTs, particularly with enhanced-bioavailability formulations. The Meriva phytosome formulation has the most osteoarthritis-specific trial data of any curcumin formulation currently available [8].
Mental Health
A meta-analysis of 15 RCTs involving 1,123 adults found that curcumin may reduce depressive and anxiety symptoms in patients with chronic diseases. Evidence remains at an early stage. Curcumin is best considered adjunctive support, not a standalone treatment [9].
Cancer and Neurodegeneration
While preclinical data is extensive, current human clinical evidence does not support curcumin as a treatment for cancer or neurodegeneration. Curcumin may offer modest adjunctive benefit in Parkinson's disease when administered in bioavailability-enhanced formulations [10].
Also read: Top 10 Liposomal Supplements Benefits: Enhance Absorption & Wellness.

Curcumin Capsules: How to Choose and What to Look For
When choosing a curcumin supplement, delivery format matters more than dosage. Most curcumin supplements fail not because the dose is too low, but because standard formulations cannot effectively deliver curcumin into circulation. Look for a lipid-based liposomal or phospholipid-encapsulated curcumin. These formats protect curcumin during digestion and improve the amount that reaches your bloodstream compared to standard tablets. Confirm the product is manufactured in a WHO-GMP-certified facility; this ensures quality, purity, and stability across batches. Always take curcumin with a meal containing dietary fat, regardless of formulation. Avoid products that list only "turmeric extract" without specifying the curcuminoid percentage or delivery system; the label should state both.
Final Thoughts
The gap between what turmeric and curcumin are marketed to do and what the clinical evidence actually supports is real, but it is closable with the right formulation and realistic expectations. Curcumin has high-credibility evidence for reducing systemic inflammation and supporting metabolic health; the limitation is getting enough of it into circulation. Before buying, check the label for both the curcuminoid percentage and the delivery system. A supplement listing only "turmeric extract" without specifying either is unlikely to deliver meaningful results. Take any curcumin supplement with a fat-containing meal regardless of formulation. Cellular Prime's liposomal curcumin uses a phospholipid-based delivery system manufactured in a WHO-GMP-certified facility. For those seeking a formulation with documented delivery efficiency, it is a considered starting point rather than a marketing promise.
FAQs on Liposomal Curcumin
What is the difference between turmeric and curcumin?
Turmeric is the whole root containing curcuminoids at only 2-8% of its total weight. Curcumin is the primary bioactive compound; a 95% curcumin extract delivers roughly 12x as much per capsule as turmeric root.
Why is curcumin poorly absorbed?
Curcumin faces three barriers: poor water solubility, rapid metabolism into inactive compounds, and fast systemic elimination. Even at 12-gram oral doses, meaningful blood concentrations are not achieved without an enhanced formulation.
What does liposomal curcumin do differently?
Liposomal curcumin encapsulates the active compound in phospholipid vesicles, protecting it from breakdown during digestion. This improves the amount of curcumin that actually reaches circulation compared to a standard unenhanced extract.
What is curcumin clinically proven to do?
A 2024 meta-analysis of 103 RCTs found high-credibility evidence that curcumin significantly reduces CRP, a key inflammation biomarker. A 2025 umbrella review confirmed benefits for blood glucose, blood pressure, and insulin resistance across double-blind trials.
Can eating more turmeric replace a supplement?
Turmeric powder in food provides insufficient circulating concentrations to achieve the outcomes seen in clinical trials. Reaching therapeutic doses through diet alone is not practically achievable; enhanced curcumin formulations are the only viable alternative.
References
- Sharma, R.A., Gescher, A.J. and Steward, W.P. (2005). Curcumin: The story so far. European Journal of Cancer, 41(13), pp.1955–1968.
- Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013 Jan;15(1):195-218.
- Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998 May;64(4):353-6.
- Cuomo J, Appendino G, Dern AS, Schneider E, McKinnon TP, Brown MJ, Togni S, Dixon BM. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J Nat Prod. 2011 Apr 25;74(4):664-9.
- Schiborr C, Kocher A, Behnam D, Jandasek J, Toelstede S, Frank J. The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Mol Nutr Food Res. 2014 Mar;58(3):516-27.
- Jafari, A., Abbastabar, M., Alaghi, A., Heshmati, J., Crowe, F.L. and Sepidarkish, M. (2024). Curcumin on Human Health: A Comprehensive Systematic Review and Meta‐Analysis of 103 Randomized Controlled Trials. Phytotherapy Research, 38(12), pp.6048–6061.
- Xu Q, Lian H, Zhou R, Gu Z, Wu J, Wu Y, Li Z. Curcumin and multiple health outcomes: critical umbrella review of intervention meta-analyses. Front Pharmacol. 2025 Jun 5;16:1601204.
- Hewlings SJ, Kalman DS. Curcumin: A Review of Its Effects on Human Health. Foods. 2017 Oct 22;6(10):92.
- Yuan J, Pi C, Shen H, Zhou B, Wei Y, Dechsupa N, Zhao L. Potential therapeutic benefits of curcumin in depression or anxiety induced by chronic diseases: a systematic review of mechanistic and clinical evidence. Front Pharmacol. 2025 Aug 22;16:1638645.
- Chang YH. Curcumin as a potential therapeutic agent for Parkinson's disease: a systematic review. Front Pharmacol. 2025 Apr 22;16:1593191.